查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929449

宠物病毒快速诊断试剂盒市场（按产品类型、动物类型、技术、检测时间、最终用户和销售管道），全球预测，2026-2032年

Pet Virus Rapid Diagnosis Kit Market by Product Type, Animal Type, Technology, Assay Time, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年宠物病毒快速诊断试剂盒市值为 1.6818 亿美元，预计到 2026 年将成长至 1.8858 亿美元，到 2032 年预计将达到 2.956 亿美元，复合年增长率为 8.39%。

主要市场统计数据
基准年 2025 1.6818亿美元
预计年份：2026年 1.8858亿美元
预测年份：2032年 2.956亿美元
复合年增长率 (%) 8.39%

动物健康管理中对快速诊断和应对的需求日益增长，使得照护现场和实验室诊断成为兽医、生产者和研究机构的策略重点。人们对人畜共患感染疾病风险的认识不断提高，生物安全要求日益严格，以及为最大限度减少治疗延误所做的努力，共同推动了对可靠、快速的动物通用病毒检测解决方案的需求增长。目前，诊断试剂盒市场涵盖免疫检测、侧向层析和分子平台等多种类型，这些产品正在不断改进，以满足物种特异性需求、使用者人体工学以及多样化的操作环境。

临床医生和检查室管理人员要求检测方法能够在不影响分析完整性的前提下缩短结果週转时间，而生产商和公共卫生机构则要求采用能够与监测系统对接的标准化工作流程。因此，产品开发人员需要在提高灵敏度和特异性的同时，兼顾可製造性和易用性。同时，监管管道和报销模式也在不断发展，以适应中心实验室之外的分散式检查。本文透过重点阐述临床需求、技术成熟度和营运实际情况如何影响兽医诊断价值链中的产品设计、采购实务和部署策略，为后续分析提供了一个框架。

技术创新、分散式检查和数据协作将如何重新定义动物健康领域的诊断服务和竞争优势

动物病毒诊断生态系统正受到多种趋势的融合影响而重塑，这些趋势加速了创新并重新分配了价值链上的价值。分子化学和携带式设备的进步使得以往仅限于中心检查室的检测灵敏度能够在现场环境中实现。同时，数位化连接和基于云端的数据聚合正在将一次性诊断设备转变为即时监测网路中的节点，为临床决策和人群层面的干预措施提供资讯。

美国近期关税措施对兽医诊断领域供应链韧性、筹资策略和采购优先事项的影响

美国近期关税调整和贸易政策变化，为诊断试剂生产商和经销商的供应链规划、采购经济效益和本地化策略带来了新的考量。进口试剂、塑胶耗材和特殊组件的关税波动导致成本增加，促使企业重新评估供应商组合、重新谈判供应商合同，并探索近岸外包机会，以降低跨境成本波动带来的风险。

高解析度細項分析揭示了产品类型、目标动物、技术、最终用户、分销管道、测试时间等因素如何决定采用趋势。

细分市场观点揭示了产品开发和商业化工作的重点方向，从而满足多样化的临床和营运需求。依产品类型分類的市场结构包括：适用于批量检测通讯协定的ELISA试剂盒、专为快速照护现场筛检设计的横向流动化验试剂盒，以及提供高分析精度的PCR试剂盒，用于确证检测。每个产品系列都针对不同的应用场景，从分散式筛检到实验室层级的确证检测，这会影响采购优先顺序和培训需求。

在全球主要市场中，采用率、监管要求和分销网络方面的区域差异会影响商业和产品策略。

区域趋势对技术采纳模式、法规要求和分销策略有显着影响。在美洲，临床网路和大规模兽医服务提供者优先考虑即时检测的便利性和与电子健康记录的整合，因此推动了对兼具速度和可追溯数据输出的检测方法的需求。该地区完善的检查室基础设施也支持分子确诊检测的广泛应用，从而实现了从快速筛检开始的循序渐进的诊断流程。

兽医诊断生态系的竞争格局正受到产品系列多元化、合作研发和服务驱动型商业化的影响。

兽用病毒诊断领域的竞争活动以产品系列多元化、策略联盟以及对研发和生产规模的定向投资为特征。现有诊断公司不断拓展其兽用产品组合，包括扩大产品线、提高与仪器平台的兼容性以及增强试剂的稳定性，以降低检测间的差异。同时，一些专业供应商则专注于细分市场产品，例如高通量分子检测板和用于农场的超快速就地检验。

围绕产品设计、供应链稳健性、数位整合和客製化市场推广模式，采取切实可行的策略行动，以推动产品普及。

产业领导者应优先考虑切实可行的措施，使产品设计、供应链韧性和客户体验与不断变化的终端使用者期望保持一致。首先，投资于支援快速筛检和确诊分子检测的模组化检测平台，可以让客户以最小的再培训成本采用分级诊断管道。其次，制定完善的供应商选择计画和区域製造伙伴关係，可以降低跨境成本波动的风险，并在需求激增时提高应对力。

我们采用严谨的混合方法研究途径，结合相关人员访谈、技术审查和检验，得出了切实可行的结论。

本研究采用多方面方法，以确保研究结果对商业、临床和监管领域的决策者俱有可靠性和适用性。主要研究包括对执业兽医、诊断实验室主任、畜牧业采购负责人和检测开发技术专家进行结构化访谈，以收集关于性能要求、工作流程限制和采购标准的一线观点。次要研究包括查阅同行评审文献、监管指导文件、专利申请和製造商的技术规范，检验技术声明并阐明创新轨迹。

综合分析技术、营运韧性和以使用者为中心的设计将如何影响未来的应用和策略重点。

总而言之，动物保健领域的快速病毒诊断试剂盒正处于一个转折点，技术进步、营运需求和不断变化的法规相互交织，既带来了新的机会，也带来了新的挑战。速度、分析性能和易用性之间的平衡将决定哪些解决方案能够被临床、实验室、研究机构和生产环境广泛采用。受贸易政策和零件供应状况影响的供应链因素，在产品规划和商业化策略中扮演核心角色，迫使企业实现采购多元化并加强在地化能力。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章 美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：宠物病毒快速诊断试剂盒市场（依产品类型划分）

  • ELISA试剂盒
  • 横向流动化验盒
  • PCR试剂盒

第九章 宠物病毒快速诊断试剂盒市场（依动物类型划分）

  • 伴侣动物
    • 猫咪病毒检测套组
    • 犬病毒检测套组
  • 实验动物
  • 家畜
    • 牛病毒检测套组
    • 家禽病毒检测套组
    • 猪病毒检测套组

第十章：宠物病毒快速诊断试剂盒市场（依技术划分）

  • 免疫检测
  • 分子诊断
  • 照护现场

第十一章：按检测时间分類的宠物病毒快速诊断试剂盒市场

  • 扩大
  • 迅速地
  • 标准

第十二章：宠物病毒快速诊断试剂盒市场（依最终用户划分）

  • 诊所
  • 检查室
  • 研究所
  • 兽医诊所

第十三章：宠物病毒快速诊断试剂盒市场（依通路划分）

  • 直销
  • 经销商
  • 在线的
  • 零售药房

第十四章：宠物病毒快速诊断试剂盒市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章：宠物病毒快速诊断试剂盒市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国宠物病毒快速诊断试剂盒市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国宠物病毒快速诊断试剂盒市场

第十七章：中国宠物病毒快速诊断试剂盒市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abaxis, Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BioNote, Inc.
  • Bio-X Diagnostics
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale SA
  • Creative Diagnostics
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • IDvet
  • Merck & Co., Inc.
  • Neogen Corporation
  • NTBIO Diagnostics, Inc.
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Group Co., Ltd.
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-0A38069517A9

The Pet Virus Rapid Diagnosis Kit Market was valued at USD 168.18 million in 2025 and is projected to grow to USD 188.58 million in 2026, with a CAGR of 8.39%, reaching USD 295.60 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 168.18 million
Estimated Year [2026] USD 188.58 million
Forecast Year [2032] USD 295.60 million
CAGR (%) 8.39%

The rapid diagnose-and-respond imperative for animal health has elevated point-of-care and laboratory diagnostics into a strategic priority for veterinarians, producers, and research institutions. Growing awareness of zoonotic risk, intensifying biosecurity mandates, and the drive to minimize treatment lag have collectively increased demand for reliable, rapid virus detection solutions tailored to animals. The landscape of diagnostic kits now spans immunoassays, lateral flow devices, and molecular platforms that are being reconfigured to address species-specific needs, user ergonomics, and varied operating environments.

Clinicians and laboratory directors are seeking tests that reduce turnaround time without compromising analytical integrity, while producers and public health authorities ask for standardized workflows that integrate with surveillance systems. As a result, product developers are balancing sensitivity and specificity improvements with manufacturability and ease of use. Meanwhile, regulatory pathways and reimbursement models are evolving to accommodate decentralized testing outside central laboratories. This introduction frames the subsequent analysis by highlighting how clinical demand, technology maturation, and operational realities are shaping product design, procurement practices, and deployment strategies across the veterinary diagnostics value chain.

How technological innovation, decentralized testing, and data connectivity are redefining diagnostics delivery and competitive advantage across animal health

The diagnostic ecosystem for animal viruses is being reshaped by converging trends that accelerate innovation and redistribute value across the supply chain. Advances in molecular chemistry and portable instrumentation are enabling assay sensitivity once confined to centralized labs to be replicated in field-friendly formats. Concurrently, digital connectivity and cloud-enabled data aggregation are transforming single-use diagnostics into nodes of real-time surveillance networks that inform clinical decisions and population-level interventions.

Operational shifts are also evident: clinics and on-farm users increasingly expect assay interfaces that require minimal training, while diagnostic laboratories prioritize throughput, automation, and multiplexing capability. Manufacturers are responding by modularizing platforms to support both rapid lateral flow screening and confirmatory molecular testing within integrated workflows. Regulatory authorities are reducing friction for emergency use and conditional approvals, accelerating commercial entry for validated technologies. Together, these transformative shifts are creating a more resilient, responsive diagnostic environment in which speed, portability, and data integration determine competitive differentiation and adoption trajectories.

Impacts of recent United States tariff policies on supply chain resilience, sourcing strategies, and procurement priorities in veterinary diagnostics

Recent tariff adjustments and trade policy developments in the United States have introduced new considerations for supply chain planning, procurement economics, and localization strategies among diagnostics manufacturers and distributors. Tariff-driven cost variances for imported reagents, plastic consumables, and specialised components have prompted organizations to reassess vendor portfolios, renegotiate supplier contracts, and explore nearshoring opportunities to reduce exposure to cross-border cost volatility.

In response, many firms have accelerated qualification of alternative suppliers, prioritized dual-sourcing for critical inputs, and increased inventory buffers for high-risk items. These adaptations aim to preserve continuity of reagent supply and maintain predictable product pricing for end users. In parallel, some manufacturers are evaluating domestic contract manufacturing partners to shorten lead times and improve control over quality assurance processes. While tariffs influence cost dynamics, their most significant impact has been to catalyze operational resilience measures that alter procurement cycles, capital allocation, and the strategic calculus for geographic expansion.

High-resolution segmentation analysis revealing how product types, animal targets, technologies, end users, channels, and assay times determine adoption dynamics

A granular segmentation perspective illuminates where product development and commercialization efforts should concentrate to meet diverse clinical and operational needs. Based on Product Type, the landscape includes ELISA kits suited to batch testing protocols, lateral flow assay kits designed for rapid, point-of-care screening, and PCR kits that deliver high analytical precision for confirmatory testing. Each product family addresses different use cases, from decentralized screening to laboratory-grade confirmation, and influences procurement preferences and training requirements.

Based on Animal Type, end users manage distinct clinical pathways across Companion Animals, Laboratory Animals, and Livestock; within companion animals, diagnostics tailored to cats and dogs must account for species-specific viral targets and clinic workflow, while livestock solutions for cattle, poultry, and swine prioritize throughput, ruggedness, and integration with herd health programs. Based on Technology, choices span Immunoassay methods that balance cost and convenience, Molecular Diagnostics that emphasize sensitivity and multiplex capability, and Point Of Care options that prioritize speed and ease of use. Based on End User, clinics, diagnostic laboratories, research institutes, and veterinary hospitals exhibit different purchasing cycles, validation requirements, and volume demands that shape product configuration and service offerings. Based on Sales Channel, direct sales, distributors, online platforms, and retail pharmacy routes each present unique commercialization pathways and margin structures. Based on Assay Time, extended, rapid, and standard assay durations determine workflow alignment, clinical utility, and user acceptance, with rapid assays increasingly favored where immediate decision-making affects treatment or containment.

Regional differentiation in adoption, regulatory expectation, and distribution that shapes commercial and product strategies across major global markets

Regional dynamics exert a strong influence on technology adoption patterns, regulatory expectations, and channel strategies. In the Americas, clinical networks and large veterinary service providers emphasize point-of-care convenience and integration with electronic health records, driving demand for assays that combine speed with traceable data outputs. The region's established laboratory infrastructure also supports wider deployment of molecular confirmatory testing, enabling tiered diagnostic workflows that begin with rapid screening.

In Europe, Middle East & Africa, heterogeneity in regulatory regimes and resource availability requires flexible commercialization approaches. High-income markets within the region prioritize standardized validation and interoperability, while emerging markets demand cost-effective, robust devices that tolerate variable supply chain conditions. Public health priorities and export controls in some jurisdictions further shape procurement timelines. In the Asia-Pacific region, growth in companion animal ownership, intensified livestock production, and rapid adoption of mobile-enabled health solutions create fertile conditions for innovative kit formats and digitally enabled services. Local manufacturing capacity and regional distribution networks play a significant role in reducing lead times and enabling tailored product offerings to meet diverse user needs across each geography.

Competitive dynamics shaped by portfolio diversification, collaborative R&D, and service-centric commercialization in the veterinary diagnostics ecosystem

Competitive activity in the veterinary virus diagnostics arena is characterized by portfolio diversification, strategic partnerships, and targeted investments in R&D and manufacturing scale. Established diagnostics companies continue to broaden their veterinary portfolios through product line extensions, instrument-platform compatibility, and reagent robustness improvements that reduce per-test variability. Simultaneously, specialized vendors focus on niche offerings such as highly multiplexed molecular panels or ultra-rapid point-of-care assays designed for on-farm deployment.

Collaborations between diagnostic developers, academic research centers, and instrument manufacturers are accelerating translation of emerging biomarkers into validated assays. Contract manufacturing organizations and reagent suppliers have also become pivotal partners, enabling faster scale-up and localized production. Commercial strategies increasingly blend direct engagement with veterinary networks and digital channel expansion, while value-added services-such as remote training, assay verification kits, and data analytics dashboards-are being used to differentiate offerings and deepen customer relationships. Together, these movements point to an increasingly sophisticated competitive environment in which technological capability, go-to-market agility, and service ecosystems determine long-term traction.

Actionable strategic measures for product architecture, supply chain robustness, digital integration, and tailored go-to-market models to drive adoption

Industry leaders should prioritize a set of actionable measures that align product design, supply chain resilience, and customer experience with evolving end-user expectations. First, investing in modular assay platforms that support both rapid screening and confirmatory molecular testing will enable customers to implement tiered diagnostic pathways without extensive retraining. Second, developing robust supplier qualification programs and regional manufacturing partnerships can reduce exposure to cross-border cost fluctuations and improve responsiveness during demand surges.

Third, embedding digital connectivity and secure data management in kit design will enhance clinical utility by enabling test result traceability, aggregation for surveillance, and seamless integration with practice management systems. Fourth, tailoring go-to-market strategies by end user segment-differentiating support for clinics, diagnostic laboratories, research institutes, and veterinary hospitals-will improve adoption and lifetime value. Fifth, investing in clear, species-specific validation materials and training resources will accelerate trust among clinicians treating companion animals and producers managing livestock. Finally, leaders should consider flexible commercial models that combine device-as-a-service, reagent subscription plans, and bundled training to lower adoption barriers and create predictable revenue streams. These measures collectively increase resilience and align commercial execution with real-world clinical needs.

Rigorous mixed-methods research approach combining stakeholder interviews, technical review, and triangulation to underpin actionable conclusions

The research drew on a multi-method approach designed to ensure the reliability and applicability of findings for decision-makers across commercial, clinical, and regulatory domains. Primary research included structured interviews with practicing veterinarians, diagnostic laboratory directors, procurement managers in livestock operations, and technical specialists in assay development to capture first-hand perspectives on performance requirements, workflow constraints, and procurement criteria. Secondary research encompassed review of peer-reviewed literature, regulatory guidance documents, patent filings, and manufacturer technical specifications to validate technological claims and contextualize innovation trajectories.

Data synthesis employed triangulation techniques that compared qualitative insights with documented specifications and regulatory frameworks to identify consistent patterns and credible divergences. Internal quality controls included source verification, cross-interview validation, and methodological transparency to document assumptions and limitations. The research also incorporated scenario mapping to explore how supply chain shocks, regulatory shifts, or rapid technology breakthroughs could alter adoption pathways. This methodology provided a robust evidentiary basis for the recommendations and insights presented, while acknowledging areas where additional primary data collection or longitudinal monitoring would strengthen confidence.

Consolidated conclusions on how technology, operational resilience, and user-centric design will determine future adoption and strategic priorities

In summary, rapid viral diagnostic kits for animal health are at an inflection point where technological progress, operational demands, and regulatory evolution converge to create new opportunities and challenges. The balance of speed, analytical performance, and ease of deployment will determine which solutions earn routine use in clinics, laboratories, research settings, and production environments. Supply chain considerations, influenced by trade policies and component availability, now play a central role in product planning and commercialization strategies, prompting companies to diversify sourcing and strengthen regional capabilities.

Going forward, success will favor organizations that combine scientifically robust assays with scalable manufacturing, strong customer support, and digitally enabled workflows. By aligning product development with the nuanced needs of companion animal care, laboratory science, and livestock management, developers and distributors can deliver diagnostics that not only improve clinical outcomes but also support broader surveillance and biosecurity objectives. The insights in this summary are intended to help decision-makers prioritize investments, structure partnerships, and design offerings that respond to the practical realities of veterinary diagnostics deployment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pet Virus Rapid Diagnosis Kit Market, by Product Type

  • 8.1. ELISA Kits
  • 8.2. Lateral Flow Assay Kits
  • 8.3. PCR Kits

9. Pet Virus Rapid Diagnosis Kit Market, by Animal Type

  • 9.1. Companion Animals
    • 9.1.1. Cat Virus Kit
    • 9.1.2. Dog Virus Kit
  • 9.2. Laboratory Animals
  • 9.3. Livestock
    • 9.3.1. Cattle Virus Kit
    • 9.3.2. Poultry Virus Kit
    • 9.3.3. Swine Virus Kit

10. Pet Virus Rapid Diagnosis Kit Market, by Technology

  • 10.1. Immunoassay
  • 10.2. Molecular Diagnostics
  • 10.3. Point Of Care

11. Pet Virus Rapid Diagnosis Kit Market, by Assay Time

  • 11.1. Extended
  • 11.2. Rapid
  • 11.3. Standard

12. Pet Virus Rapid Diagnosis Kit Market, by End User

  • 12.1. Clinics
  • 12.2. Diagnostic Laboratories
  • 12.3. Research Institutes
  • 12.4. Veterinary Hospitals

13. Pet Virus Rapid Diagnosis Kit Market, by Sales Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online
  • 13.4. Retail Pharmacy

14. Pet Virus Rapid Diagnosis Kit Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pet Virus Rapid Diagnosis Kit Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pet Virus Rapid Diagnosis Kit Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Pet Virus Rapid Diagnosis Kit Market

18. China Pet Virus Rapid Diagnosis Kit Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abaxis, Inc.
  • 19.6. Abbott Laboratories
  • 19.7. Bio-Rad Laboratories, Inc.
  • 19.8. bioMerieux SA
  • 19.9. BioNote, Inc.
  • 19.10. Bio-X Diagnostics
  • 19.11. Boehringer Ingelheim International GmbH
  • 19.12. Ceva Sante Animale S.A.
  • 19.13. Creative Diagnostics
  • 19.14. Heska Corporation
  • 19.15. IDEXX Laboratories, Inc.
  • 19.16. IDvet
  • 19.17. Merck & Co., Inc.
  • 19.18. Neogen Corporation
  • 19.19. NTBIO Diagnostics, Inc.
  • 19.20. QIAGEN N.V.
  • 19.21. Randox Laboratories Ltd.
  • 19.22. Thermo Fisher Scientific Inc.
  • 19.23. URIT Medical Electronic Group Co., Ltd.
  • 19.24. Virbac S.A.
  • 19.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ELISA KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ELISA KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PCR KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CAT VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CAT VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CAT VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DOG VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DOG VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DOG VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LABORATORY ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LABORATORY ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LABORATORY ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CATTLE VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CATTLE VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CATTLE VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POULTRY VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POULTRY VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POULTRY VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SWINE VIRUS KIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SWINE VIRUS KIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SWINE VIRUS KIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY EXTENDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY EXTENDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY EXTENDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RAPID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RAPID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RAPID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY STANDARD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY STANDARD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY STANDARD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 199. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 200. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 208. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 209. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY ASSAY TIME, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PET VIRUS RAPID DIAGNOSIS KIT MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)